PharmaBoardroom

Top 10 Pharma Companies in Norway

The top 10 pharma companies in Norway ranked by 2019 turnover according to IQVIA data. The Norwegian market is dominated by multinationals, with…

Top 15 Pharma Companies in Norway 2019

The Top 15 pharmaceutical companies in Norway ranked by sales turnover in 2019. The market is dominated by multinationals, with Novartis, Pfizer and…

MSD to Build USD 1.3 Billion London Research Hub in Boon for…

US Merck (MSD globally) is following through on a 2017 commitment to invest in a new early research hub in central London, with plans to open the…

Sanofi Buys Principia for USD 3.7 Billion as Part of Specialty…

Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in cash, giving the French giant full…

The Long Read: Belgium – The Multifaceted

Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical powerhouses of Germany and France,…

Pharma Faces: Sonja Willems, Janssen Benelux

Belgium is a vitally important country for Johnson & Johnson's pharmaceutical arm, Janssen, globally. In addition to their R&D centre and a…

Hospital Reform in Belgium: A Guarantee of Better Care?

Belgium’s healthcare system was ranked fourth in Europe in 2019, outperforming its peers across a number of metrics including a relatively high…

Sanofi Pasteur Appoints Thomas Triomphe as New Executive Vice…

With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe as the new head of its vaccines…

Medicines for Europe Leadership Team on Generics Industry COVID…

In conversation with PharmaBoardroom Christoph Stoller and Adrian Van den Hoven of Medicines for Europe, the association representing the European…

Serge Kemps – CEO, Nipro Medical Europe

Serge Kemps, CEO of Nipro Medical Europe, sits down with PharmaBoardroom to shed light on Nipro’s unique corporate culture based on the Japanese…

Christoph Stoller – President & Adrian van den Hoven…

In the wake of the publication of Medicines for Europe’s Lessons Learned from COVID-19 policy paper, Christoph Stoller & Adrian van den Hoven…

Launching Zolgensma® in Belgium: Lessons Learned

In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy Zolgensma® for the ultra-rare…

Tagged with EU